** Shares of Co-Diagnostics Inc CODX.O rise 5.2% to $6.29
in early trade after shipping monkeypox testing reagents to one
of its international distributors
** Co adds the products were designed and developed on
expedited basis to meet the demands in distributor's region but
does not provide any other details urn:newsml:reuters.com:*:nPn8jR7rGa
** More than 7,600 cases of monkeypox disease has been
confirmed in over 50 countries in which disease is not endemic
urn:newsml:reuters.com:*:nL5N2XF1XF
** All 3 brokerages covering CODX rate stock "buy" or
higher; their median PT is $14
** Despite session's gain, stock down 29% YTD
(Reporting by Leroy Leo in Bengaluru)
((Leroy.Dsouza@thomsonreuters.com ; Twitter: https://twitter.com/LeroyLeo7;))